CMS assigns Barostim to APC 1580; payment ~$45,000 continues in 2025

CVRx, Inc.

Centers for Medicare and Medicaid Services assigned Barostim procedure to New Technology APC 1580.
APC payment of approximately $45,000 will continue in 2025 per Medicare OPPS final rule.
Announcement on November 4, 2024, confirms favorable reimbursement for CVRx's Barostim therapy.

item 8.01

CVRx, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-24-113676

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.